Petros Pharmaceuticals Establishes Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil)

Go back to Petros Pharmaceuticals Establishes Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil)
(NASDAQ: PTPI) Delayed: 3.40 +0.18 (5.59%)
Previous Close $3.22    52 Week High
Open $3.25    52 Week Low
Day High $3.42    P/E N/A 
Day Low $3.13    EPS
Volume 11,346